These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 21244567)

  • 1. Commentary: Revisiting the data: mild resting glabellar lines improve with onabotulinumtoxinA.
    Contreras ME; Cohen JL
    Dermatol Surg; 2010 Dec; 36 Suppl 4():2172-4. PubMed ID: 21244567
    [No Abstract]   [Full Text] [Related]  

  • 2. OnabotulinumtoxinA treatment of mild glabellar lines in repose.
    Carruthers A; Carruthers J; Lei X; Pogoda JM; Eadie N; Brin MF
    Dermatol Surg; 2010 Dec; 36 Suppl 4():2168-71. PubMed ID: 21134048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Noninferiority of incobotulinumtoxinA, free from complexing proteins, compared with another botulinum toxin type A in the treatment of glabellar frown lines.
    Sattler G; Callander MJ; Grablowitz D; Walker T; Bee EK; Rzany B; Flynn TC; Carruthers A
    Dermatol Surg; 2010 Dec; 36 Suppl 4():2146-54. PubMed ID: 21134045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase IV study comparing incobotulinumtoxinA and onabotulinumtoxinA using a 1:1.5 dose-conversion ratio for the treatment of glabellar frown lines.
    Prager W; Rappl T
    J Cosmet Dermatol; 2012 Dec; 11(4):267-71. PubMed ID: 23174049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Botulinum toxin type A for the treatment of glabellar rhytides.
    Carruthers A; Carruthers J
    Dermatol Clin; 2004 Apr; 22(2):137-44. PubMed ID: 15222573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized, placebo-controlled study of a new botulinum toxin type a for treatment of glabellar lines: efficacy and safety.
    Brandt F; Swanson N; Baumann L; Huber B
    Dermatol Surg; 2009 Dec; 35(12):1893-901. PubMed ID: 19549186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomised, double-blind comparison of 20 units of onabotulinumtoxinA with 30 units of incobotulinumtoxinA for glabellar lines.
    Moers-Carpi M; Dirschka T; Feller-Heppt G; Hilton S; Hoffmann K; Philipp-Dormston WG; Rütter A; Tan K; Chapman MA; Fulford-Smith A
    J Cosmet Laser Ther; 2012 Dec; 14(6):296-303. PubMed ID: 23057624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficacy and safety of liquid-type botulinum toxin type A for the management of moderate to severe glabellar frown lines.
    Kim JE; Song EJ; Choi GS; Lew BL; Sim WY; Kang H
    Plast Reconstr Surg; 2015 Mar; 135(3):732-741. PubMed ID: 25719692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolution of Facial Aesthetic Treatment Over Five or More Years: A Retrospective Cross-sectional Analysis of Continuous OnabotulinumtoxinA Treatment.
    Carruthers A; Sadick N; Brandt F; Trindade de Almeida AR; Fagien S; Goodman GJ; Raspaldo H; Smith K; Darmody S; Gallagher CJ; Street J; Romagnano L
    Dermatol Surg; 2015 Jun; 41(6):693-701. PubMed ID: 25973559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repeated OnabotulinumtoxinA Treatment of Glabellar Lines at Rest Over Three Treatment Cycles.
    Carruthers A; Carruthers J; Fagien S; Lei X; Kolodziejczyk J; Brin MF
    Dermatol Surg; 2016 Sep; 42(9):1094-101. PubMed ID: 27427996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Commentary: long-term treatment of glabellar rhytides using onabotulinumtoxina.
    Carruthers A; Carruthers J
    Dermatol Surg; 2011 Jul; 37(7):929-30. PubMed ID: 21711406
    [No Abstract]   [Full Text] [Related]  

  • 12. Two-plane injection of botulinum toxin for the treatment of glabellar frown lines.
    Ozsoy Z; Gözü A; Genç B
    Plast Reconstr Surg; 2002 Jul; 110(1):371-2. PubMed ID: 12087307
    [No Abstract]   [Full Text] [Related]  

  • 13. Deep resting glabellar rhytides respond to BTX-A and Hylan B.
    Carruthers J; Carruthers A; Maberley D
    Dermatol Surg; 2003 May; 29(5):539-44. PubMed ID: 12752525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Commentary: Efficacy and safety of a novel botulinum toxin topical gel.
    West TB
    Dermatol Surg; 2010 Dec; 36 Suppl 4():2119-20. PubMed ID: 21244565
    [No Abstract]   [Full Text] [Related]  

  • 15. A double-blind, randomized, placebo-controlled, two-dose comparative study of botulinum toxin type A for treating glabellar lines in Japanese subjects.
    Kane MA
    Aesthetic Plast Surg; 2008 Nov; 32(6):933-5. PubMed ID: 18685887
    [No Abstract]   [Full Text] [Related]  

  • 16. Alteration of Skin Mechanical Properties in Patients Undergoing Botulinum Toxin Type A Injections of Forehead Rhytides.
    Min P; Zhang Z; Grassetti L; Perdanasari AT; Torresetti M; Pu Z; Zhang Y; Han S; Marsili R; Zhang YX; di Benedetto G; Lazzeri D
    Aesthetic Plast Surg; 2016 Jun; 40(3):410-20. PubMed ID: 26944891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two different types of botulinum toxins: Is there a difference in efficacy and longevity?
    Shome D; Kapoor R; Khare S
    J Cosmet Dermatol; 2019 Dec; 18(6):1635-1641. PubMed ID: 31135088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase 3 Study of OnabotulinumtoxinA Distributed Between Frontalis, Glabellar Complex, and Lateral Canthal Areas for Treatment of Upper Facial Lines.
    De Boulle K; Werschler WP; Gold MH; Bruce S; Sattler G; Ogilvie P; Street J; Larsen KE; Yushmanova I; Lei X; Lee E; Vitarella D; Mao C
    Dermatol Surg; 2018 Nov; 44(11):1437-1448. PubMed ID: 30096106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy, Patient-Reported Outcomes, and Safety for Millennial Subjects Treated With OnabotulinumtoxinA for Moderate to Severe Horizontal Forehead Lines.
    Palm MD; Few J; Patel T; Safa M; Drinkwater A; Mao C; Garcia JK
    Dermatol Surg; 2020 May; 46(5):653-661. PubMed ID: 31625954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Randomized, Double-Blind Trial to Investigate the Equivalence of IncobotulinumtoxinA and OnabotulinumtoxinA for Glabellar Frown Lines.
    Kane MA; Gold MH; Coleman WP; Jones DH; Tanghetti EA; Alster TS; Rohrer TE; Burgess CM; Shamban AT; Finn E
    Dermatol Surg; 2015 Nov; 41(11):1310-9. PubMed ID: 26509943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.